The future of GLP-1RAs in anti-inflammatory therapy looks promising, with ongoing research aiming to optimize their therapeutic use, develop patient-specific treatment paradigms, and explore novel applications
A case of vesiculopustular eruption occurred 6 weeks after liraglutide use, with non-grouped vesicles and red borders on the thorax, abdomen, face, neck, arms, and lower extremities
While consensus does not exist regarding the exact synergistic mechanisms by which dual-agonists work, the addition of GIP agonism is posited to improve the HbA1c control and weight loss offered by GLP-1 agonists alone by enhancing insulin secretion, decreasing energy consumption, and stimulating satiety in the hypothalamus
J., Cheng, C
Combining incretin-based drugs and RAAS inhibitors: more cons than pros
Our CJC-1295 buccal peptide strips deliver this powerful compound directly through the tissue under your tongue